|Bid||5.40 x 2200|
|Ask||5.65 x 1200|
|Day's Range||5.30 - 5.81|
|52 Week Range||5.02 - 23.02|
|Beta (5Y Monthly)||1.00|
|PE Ratio (TTM)||N/A|
|Earnings Date||Apr 13, 2022 - Apr 18, 2022|
|Forward Dividend & Yield||N/A (N/A)|
|Ex-Dividend Date||Oct 14, 1999|
|1y Target Est||3.00|
PHILADELPHIA, May 20, 2022--Rite Aid (NYSE: RAD) today announced it will begin administering a booster dose of Pfizer’s COVID-19 vaccine at select locations for eligible children ages 5 to 11, following approval by the Centers for Disease Control and Prevention (CDC) and the Food and Drug Administration (FDA) on Thursday. Bartell Drugs, owned by Rite Aid Corporation, will also begin administering boosters to this age group at select Seattle and Western Washington locations.
SAN FRANCISCO, May 03, 2022--Afterpay, the leader in "Buy Now, Pay Later" (BNPL) payments, and trusted care retailer Rite Aid (NYSE: RAD) announced their partnership today, offering Rite Aid’s online shoppers a new way to pay for everyday items in four installments at no additional cost when you pay on time. This partnership will help customers access and spend responsibly on everyday goods with Afterpay’s powerful budgeting tool.
PHILADELPHIA, April 27, 2022--Rite Aid (NYSE: RAD) today announced that nearly 98% of its retail pharmacies across the 17 states it serves now offers FDA-authorized COVID-19 oral antiviral medications, Pfizer’s Paxlovid or Merck’s Molnupiravir, with a prescription from their healthcare provider.